In breast invasive carcinoma no predictive value was observed by SLC6A14 , SLC12A4 or SLC25A15 alone, but there was a nonsignificant trend for reduced survival in SLC6A14 -high combined with SLC12A4 -high or SLC25A15 -high expression (Extended Data Fig. 7b ).
← all excerpts
Phenotypic profiling of solute carriers characterizes serine transport in cancer.
1
—
—